Vital Therapies Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Vital Therapies Inc
TickerIMUX
CIK #0001280776
CUSIP4525EP101
SectorLife Sciences - Pharmaceutical Preparations
Address15222 Avenue of Science, Suite B, San Diego, CA 92128
Source [EDGAR]
Reg D Offering (Form D) Filed Raised Terms
Immunic Inc 2026-03-04 200.0 M Exemption: 506(b) · Duration: One year or less · Commission: $12,000,000 · Revenue: Decline to Disclose
Vital Therapies Inc 2014-02-04 13.9 M Exemption: 506(c) · Duration: One year or less · Revenue: Decline to Disclose
CIK Filing 2011 - 2026
[0001280776] 10-K
[0001280776] 10-Q
[0001280776] 3
[0001280776] 4
[0001280776] 5
[0001280776] 8-K
[0001280776] D
[0001280776] SC 13D
[0001280776] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Integrated Core Strategies US LLC Immunic Inc [2026-05-06] 0.0
Avidity Partners Management LP Immunic Inc [2026-04-17] 0.0
Deep Track Capital LP Immunic Inc [2026-03-04] 0.0
Trails Edge Capital Partners LP Immunic Inc [2026-02-24] 0.0
Commodore Capital LP Immunic Inc [2026-02-24] 0.0
Biotechnology Value Fund L P Immunic Inc [2026-02-20] 0.0
Vivo Opportunity Fund Holdings LP Immunic Inc [2026-02-20] 0.0
Soleus Capital Master Fund LP Immunic Inc [2026-02-19] 0.0
Janus Henderson Group PLC Immunic Inc [2025-12-08] 0.0
Alyeska Investment Group LP Immunic Inc [2025-08-14] 0.0
Nantahala Capital Management LLC Immunic Inc [2025-08-14] 0.0
683 Capital Management LLC Immunic Inc [2025-08-08] 0.0
Aberdeen Group PLC Immunic Inc [2025-07-31] 0.0
Adage Capital Management LP Immunic Inc [2024-11-12] 6.21
Biotechnology Value Fund L P Immunic Inc [2024-01-18] 5.2
Janus Henderson Group PLC Immunic Inc [2024-01-18] 7.4
Avidity Partners Management LP Immunic Inc [2024-01-16] 0.9
Soleus Private Equity Fund III LP Immunic Inc [2024-01-10] 5.4
Oetker-Von Franquet Suzanne Madeleine Immunic Inc [2022-11-28] 5.0
ROI Verwaltungs GmbH Immunic Inc [2022-11-25] 5.0
Oetker Roland Immunic Inc [2022-11-25] 5.0
Point72 Asset Management LP Immunic Inc [2022-10-24] 4.9
Commodore Capital LP Immunic Inc [2022-10-21] 0.3
Deep Track Capital LP Immunic Inc [2022-10-20] 0.29
RTW Investments LP Immunic Inc [2022-02-14] 6.5
Oetker Roland Immunic Inc [2021-02-19] 5.1
FMR LLC Immunic Inc [2021-02-08] 0.0
Altium Capital Management LP Immunic Inc [2020-05-04] 7.4
Artal International SCA Immunic Inc [2019-12-20] 5.9
Fund NV Immunic Inc [2019-04-23] 13.56
LSP V Cooperatieve UA Immunic Inc [2019-04-22] 21.38
Global Life Bioventure V SARL Immunic Inc [2019-04-22] 13.56
IBG Risikokapitalfonds II GmbH & Co KG Immunic Inc [2019-04-22] 7.79
Eckenstein-Geigy-Stiftung Immunic Inc [2019-04-22] 6.25
Satter Muneer A Vital Therapies Inc [2017-04-04] 26.9
Victory Capital Management Inc Vital Therapies Inc [2016-09-23] 6.95
RS Investment Management Co LLC Vital Therapies Inc [2016-02-12] 7.13
KCK Ltd Vital Therapies Inc [2015-11-05] 6.2
FMR LLC Vital Therapies Inc [2015-02-13] 0.0
Satter Muneer A Vital Therapies Inc [2015-02-12] 28.6
Form 3/4/5 Filer 2011 - 2026
Neermann Joerg
Immunic Inc
Skerjanec Simona
Rudick Richard Alan
Phillips Barclay A
Congleton Jon
Bonney Michael W
Tardio Jason
Whaley Glenn
Vitt Daniel
Howson Tamar D
Lundgren Erik
Panzara Michael A
Nagel Robert Thorvald
BVF Inc/IL
Biotechnology Value Trading Fund OS LP
BVF Partners L P/IL
Lampert Mark N
BVF GP Holdings LLC
BVF II GP LLC
BVF Partners OS Ltd
Biotechnology Value Fund L P
Biotechnology Value Fund II LP
BVF I GP LLC
Nash Duane
Muehler Andreas
Toernsen Monika Maria
Ossipow Vincent
van den Bossche Jan
Groeppel Manfred
Patel Sanjay S
Fund NV
LSP V Management BV
LSP V Cooperatieve UA
Nessi Claudio
Omega Fund V LP
Paster Anne-Mari
Stampacchia Otello
Omega Fund V GP Manager Ltd
Global Life Bioventure V Sarl
Lim Richard J
Omega Fund V GP LP
Cox Russell J
Ashley Robert A
Swanson Michael V
Dunn John Michael
Halperin Errol R
Bienaime Jean Jacques
Godshall Douglas Evan
Hasnain Faheem
Satter Muneer A
Cohen Cheryl
Stern Aron
Henry Andrew
Murawski Richard M
Millis J Michael
Sears Lowell
Winters Terence E
Steer Randolph C
Croxford Philip M
Loewen Andrea
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Whaley Glenn
Stock Appreciation Right · derivative
2025-07-16 Grant 560,000 $0.00
Whaley Glenn
Stock Appreciation Right · derivative
2025-07-16 Grant 560,000 $0.00
Whaley Glenn
Stock Appreciation Right · derivative
2025-07-16 Grant 280,000 $0.00
Whaley Glenn
Stock Appreciation Right · derivative
2025-07-16 Grant 280,000 $0.00
Whaley Glenn
Stock Appreciation Right · derivative
2025-07-16 Grant 280,000 $0.00
Nash Duane
Stock Appreciation Right · derivative
2025-07-16 Grant 315,000 $0.00
Nash Duane
Stock Appreciation Right · derivative
2025-07-16 Grant 315,000 $0.00
Nash Duane
Stock Appreciation Right · derivative
2025-07-16 Grant 630,000 $0.00
Nash Duane
Stock Appreciation Right · derivative
2025-07-16 Grant 630,000 $0.00
Nash Duane
Stock Appreciation Right · derivative
2025-07-16 Grant 315,000 $0.00
Vitt Daniel
Stock Appreciation Right · derivative
2025-07-16 Grant 860,000 $0.00
Vitt Daniel
Stock Appreciation Right · derivative
2025-07-16 Grant 860,000 $0.00
Vitt Daniel
Stock Appreciation Right · derivative
2025-07-16 Grant 1,720,000 $0.00
Vitt Daniel
Stock Appreciation Right · derivative
2025-07-16 Grant 1,720,000 $0.00
Vitt Daniel
Stock Appreciation Right · derivative
2025-07-16 Grant 860,000 $0.00
Muehler Andreas
Stock Appreciation Right · derivative
2025-07-16 Grant 330,000 $0.00
Muehler Andreas
Stock Appreciation Right · derivative
2025-07-16 Grant 660,000 $0.00
Muehler Andreas
Stock Appreciation Right · derivative
2025-07-16 Grant 660,000 $0.00
Muehler Andreas
Stock Appreciation Right · derivative
2025-07-16 Grant 330,000 $0.00
Muehler Andreas
Stock Appreciation Right · derivative
2025-07-16 Grant 330,000 $0.00
showing 20 of 200 most recent transactions
13F Ownership Over TimeHoldersShares Held
2026-03-31 75 64,528,476
2025-12-31 61 51,480,452
2025-09-30 63 42,887,426
2025-06-30 57 50,229,245
2025-03-31 68 41,701,812
2024-12-31 68 54,404,327
2024-09-30 63 56,298,558
2024-06-30 58 56,099,302
2024-03-31 62 57,629,577
2023-12-31 53 15,804,505
2023-09-30 56 18,534,056
2023-06-30 66 20,435,975
Form 13F Holdings
Firm Period DFND Voting Shares
Prev | Page 1 | Next
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com